Click here to visit hairlosshelp.com

Issue 2 - Jan 28, 2001
Click here for previous issues

Enter your email address to subscribe
CONTENTS
Dr Gho behind schedule? FDA proposes new tissue handling regulations
Transplant Repair Procedure Update New hair loss trials halted
The Bald Truth Expands Consumer Survey
Emu Oil - A Closer Look Expert Advice
Gel Prevents Chemotherapy Hair Loss Gene Chip Study Q&A
***Revivogen promotion extended until Feb 10th - Click here for Exclusive offers***
 
Ask an Expert

Need help or have a question?

Our resident hair loss experts are available to answer all your hair loss questions. There are almost 500 questions that have already been asked and answered, chances are your question may be one of them. We have now added a search feature on the home page so you can get the answers you need instantly. If you still can't find the answer then submit the question to our growing number of experts by going to the Ask An Expert section

 
Question of the Week

Nick asked: "Mr. Kozol, Based on your previous responses to questions, you state that the DHT produced within the body is more important (causes more harm to the hair) than locally produced DHT in MPB. The makers of Revivogen state "A: The blood levels of DHT may play a minor role in Androgenetic Alopecia but it is the locally produced DHT which plays the major role. If you look at any physiology text book (such as Guyton's Medical Physiology) you can see that the majority of DHT production takes place at the site where it exerts its effects. Also there is a high concentration of type 2 isoenzyme within the hair follicle itself and a higher concentration of the type 1 form within the scalp and sebaceous glands which feed into the hair follicle. Together they can produce more DHT locally than what blood brings to the hair follicle. Also most researchers now believe that it is the locally produced DHT that is involved in Androgenetic Alopecia rather than the circulatory DHT. Finally there is new evidence about effectiveness of topical inhibition of DHT on hair growth by Dr. Christiano which provides support for this theory. Can you please comment on this? Thank you and Best Regards, Nick"

Aaron J. Kozol, R.Ph answered: "Nick, Thanks for the questions. There is no doubt that local and systemic DHT both play some role in MPB. Some researchers have shown significant results by inhibiting only local DHT while others have shown results inhibiting systemically. My past answers were not intended to rank systemic DHT as the bigger enemy. DHT, no matter where it is produced, will most likely have deleterious effects on the hair follicle. The disadvantage to only inhibiting DHT production locally is that DHT produced in other areas may still be presented to the receptor in the follicle. If it were entirely true that circulating DHT levels do not affect MPB, then we would not expect to see hair loss from anabolic steroid use. Also, we would expect a topical DHT inhibitor such as azelaic acid to be more successful than finasteride. Not suprisingly, anabolic steroids do potentiate hair loss for some people. Azelaic acid does work well for some people, but in my experience is a bit less effective than oral finasteride. Topical finasteride appears to be ineffective. The only conclusion I can draw at this point is that DHT - no matter where it is produced - may exert negative effects upon susceptible follicles. I do feel that topical DHT inhibitors have something to offer, but I don't believe you maximize their potential unless you inhibit DHT systemically or block the receptor as well. Aaron Kozol, RPh MTTS www.hairlosspharmacy.com

 

Copyright 2001 hairlosshelp.com All Rights Reserved000 hairlosshelp.com - Disclaimer